Alitretinoin Topical Dosage
Medically reviewed by Drugs.com. Last updated on Oct 15, 2024.
Applies to the following strengths: 0.1%
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Kaposi's Sarcoma
Initial dose: Apply a generous coating of gel to cutaneous lesions 2 times a day; may gradually increase applications to 3 to 4 times a day based on individual lesion tolerance
Comments:
- If application site toxicity occurs, the application frequency may be reduced; if irritation is severe, application may be temporarily discontinued for a few days until symptoms subside.
- Therapy should be continued as long as the patient is deriving benefit.
Use: For the topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma; this drug is not indicated when systemic therapy is needed (e.g., more than 10 new lesions in prior month, symptomatic lymphedema, symptomatic pulmonary Kaposi's sarcoma, or symptomatic visceral involvement)
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- For topical use only
- Avoid application to normal skin surrounding lesions and on or near mucosal body surfaces due to potential for irritation.
- Allow gel to dry for 3 to 5 minutes before covering with clothing.
- Occlusive dressings should not be used.
General:
- There is no experience using this drug for the systemic treatment of Kaposi's sarcoma.
- Response of Kaposi's sarcoma lesions may be seen as early as 2 weeks after initiating therapy; however, most patients require longer treatment. Some patients required over 14 weeks to respond to therapy and in clinical trials, up to 96 weeks of treatment was observed.
Patient advice:
- Minimize exposure of treated areas to sunlight and sunlamps while using this drug.
More about alitretinoin topical
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- During pregnancy
- Drug class: miscellaneous topical agents
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.